← Evidence map

ArticleCurrent oncology (Toronto, Ont.)2016

Progression pattern and adverse events with bevacizumab in glioblastoma.

A Mamo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

11 papers cite it

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 27803607